IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

all

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 31 May 2013 | Removal date: open ended
Still in force

Import tariff

On 31 May 2013, the Brazilian Foreign Trade Council (Camex) published resolution no. 37/13 reducing import tariffs on seven drugs. The items have been labeled as non-tariff products ('ex-tarifários') and added to the Mercosur List of Exceptions to the Common External Tariff (Letec). The goal is to reduce the costs for the public health care system SUS (Sistema Único de Saúde).
 
The measure came into effect on 31 May 2013 and affects the following drugs:
1. Abatacept (NCM 3002.10.29), reduced from 2% - 0%
2. Cetolizumab pegol (NCM 3002.10.29), reduced from 2% - 0%
3. Golimumab (NCM 3002.10.29) , reduced from 2% - 0%
4. Telaprevir (NCM 3004.90.69, already on Letec) reduce from 8%-0%
5. Boceprevir (NCM 3004.90.79, already on Letec) reduce from 8%-0%
6. Palivizumab (NCM 3002.10.39, already on Letec) reduced from 2% - 0%
7. Hemoderivatives factor VIII (NCM 3002.10.39), reduced from 2% - 0%

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products
3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micr
300210 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
3004 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packin
300490 Other

Please report this page in case you detect an inaccuracy in its content.